Topline results were announced from a trial evaluating dapirolizumab pegol in patients with moderate to severe systemic lupus erythematosus.

Gamified digital mental health interventions (DMHIs) may offer benefits for youth with attention-deficit/hyperactivity disorder (ADHD) or depressive disorder.

The age-adjusted suicide rate increased in 2021 and 2022, following a decline from 2018 to 2020, reaching 14.2 per 100,000 standard population in 2022.

Patients with RA face greater health care expenditures and a lower quality of life compared with the general population.

Regional anesthesia may reduce chronic postsurgical pain up to 6 months and mitigate risk for persistent opioid use after elective noncardiac surgery.

The FDA announced that it has accepted the supplemental sNDA for roflumilast foam 0.3% in those with scalp and body psoriasis over 12.

Emotion regulation and pain catastrophizing influenced pain severity and interference in patients taking opioid medications for chronic noncancer pain.